DP-R213

DRUG2 trials

Sponsors

Alvogen Korea

Conditions

Healthy

Phase 1

DP-R213 Pharmacokinetics Study

CompletedNCT02762643

Alvogen KoreaHealthy

Start: 2016-05-31End: 2016-08-31Updated: 2016-11-01

DP-R213 Phase 1 Pharmacokinetics Study

CompletedNCT03010267

Alvogen KoreaHealthy

Start: 2017-01-03End: 2017-03-29Updated: 2017-06-05

Related Papers

A randomized, open-label, single-dose, two-way crossover study to assess the pharmacokinetics between two tablets of fixed-dose combination formulation with raloxifene and cholecalciferol and concomitant administration of each agents in healthy male volunteers

Translational and Clinical Pharmacology2022-01-012 citations